Detalhe da pesquisa
1.
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.
Liver Int
; 43(1): 208-220, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924447
2.
A TGFß-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease.
Sci Transl Med
; 15(713): eabq5930, 2023 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703354
3.
Indian Hedgehog release from TNF-activated renal epithelia drives local and remote organ fibrosis.
Sci Transl Med
; 15(698): eabn0736, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256934
4.
In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma.
Cancer Res
; 82(8): 1548-1559, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074757
5.
Developing models of cholangiocarcinoma to close the translational gap in cancer research.
Expert Opin Investig Drugs
; 30(4): 439-450, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513027
6.
A Cell/Cilia Cycle Biosensor for Single-Cell Kinetics Reveals Persistence of Cilia after G1/S Transition Is a General Property in Cells and Mice.
Dev Cell
; 47(4): 509-523.e5, 2018 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458140